Literature DB >> 15151996

Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.

Christopher L Kepley1, Sharven Taghavi, Graham Mackay, Daocheng Zhu, Penelope A Morel, Ke Zhang, John J Ryan, Leslie S Satin, Min Zhang, Pier P Pandolfi, Andrew Saxon.   

Abstract

Signaling through the high affinity IgE receptor FcepsilonRI on human basophils and rodent mast cells is decreased by co-aggregating these receptors to the low affinity IgG receptor FcgammaRII. We used a recently described fusion protein, GE2, which is composed of key portions of the human gamma1 and the human epsilon heavy chains, to dissect the mechanisms that lead to human mast cell and basophil inhibition through co-aggregation of FcgammaRII and FcepsilonRI. Unstimulated human mast cells derived from umbilical cord blood express the immunoreceptor tyrosine-based inhibitory motif-containing receptor FcgammaRII but not FcgammaRI or FcgammaRIII. Interaction of the mast cells with GE2 alone did not cause degranulation. Co-aggregating FcepsilonRI and FcgammaRII with GE2 1) significantly inhibited IgE-mediated histamine release, cytokine production, and Ca(2+) mobilization, 2) reduced the antigen-induced morphological changes associated with mast cell degranulation, 3) reduced the tyrosine phosphorylation of several cellular substrates, and 4) increased the tyrosine phosphorylation of the adapter protein downstream of kinase 1 (p62(dok); Dok), growth factor receptor-bound protein 2 (Grb2), and SH2 domain containing inositol 5-phosphatase (SHIP). Tyrosine phosphorylation of Dok was associated with increased binding to Grb2. Surprisingly, in non-stimulated cells, there were complexes of phosphorylated SHIP-Grb2-Dok that were lost upon IgE receptor activation but retained under conditions of Fcepsilon-Fcgamma co-aggregation. Finally, studies using mast cells from Dok-1 knock-out mice showed that IgE alone triggers degranulation supporting an inhibitory role for Dok degranulation. Our results demonstrate how human FcepsilonRI-mediated responses can be inhibited by co-aggregation with FcgammaRIIB and implicate Dok, SHIP, and Grb2 as key intermediates in regulating antigen-induced mediator release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151996     DOI: 10.1074/jbc.M404318200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma.

Authors:  Sarah K Norton; Dayanjan S Wijesinghe; Anthony Dellinger; Jamie Sturgill; Zhiguo Zhou; Suzanne Barbour; Charles Chalfant; Daniel H Conrad; Christopher L Kepley
Journal:  J Allergy Clin Immunol       Date:  2012-06-02       Impact factor: 10.793

Review 2.  Future therapies for food allergies.

Authors:  Anna Nowak-Węgrzyn; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

3.  Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2.

Authors:  Judith A Woodfolk; Jill Glesner; Paul W Wright; Christopher L Kepley; Mi Li; Martin Himly; Lyndsey M Muehling; Alla Gustchina; Alexander Wlodawer; Martin D Chapman; Anna Pomés
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

Review 4.  Chimeric human fcgamma-allergen fusion proteins in the prevention of allergy.

Authors:  Ke Zhang; Daocheng Zhu; Christopher Kepley; Tetsuya Terada; Andrew Saxon
Journal:  Immunol Allergy Clin North Am       Date:  2007-02       Impact factor: 3.479

5.  Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody.

Authors:  Mi Li; Alla Gustchina; Jerry Alexandratos; Alexander Wlodawer; Sabina Wünschmann; Christopher L Kepley; Martin D Chapman; Anna Pomés
Journal:  J Biol Chem       Date:  2008-06-02       Impact factor: 5.157

Review 6.  Signal transduction and chemotaxis in mast cells.

Authors:  Petr Draber; Ivana Halova; Iva Polakovicova; Toshiaki Kawakami
Journal:  Eur J Pharmacol       Date:  2015-05-02       Impact factor: 4.432

Review 7.  New approaches to allergen immunotherapy.

Authors:  Christopher L Kepley
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

Review 8.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

Review 9.  Past, present, and future of anti-IgE biologics.

Authors:  Pascal Guntern; Alexander Eggel
Journal:  Allergy       Date:  2020-04-21       Impact factor: 13.146

Review 10.  Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts.

Authors:  J Wisniewski; R Agrawal; J A Woodfolk
Journal:  Clin Exp Allergy       Date:  2013-02       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.